Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
The Canadian Cannabis Report - Monday, Mar. 7
March 07, 2022
Tickers
ACB
CGC
CNBS
CRON
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Marijuana & Psychedelic Compounds-Based Drug Stocks Index Down, Again
March 06, 2022
Tickers
ALID
CRBP
FTRP
RVVTF
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Sail Through the Choppy Market With These 4 Low-Beta Stocks
March 05, 2022
Tickers
HMN
INVA
MRVI
VIVO
Tags
Financial
Market News
Stocks / Equities
From
TalkMarkets
Week In Review: Adagene Forms $2.5 Billion, Four-Drug Partnership With Sanofi
March 05, 2022
Tickers
ADAG
AQST
LEGN
SNY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Sacklers Reach $6 Billion Deal Over Purdue Pharma's OxyContin Lawsuits
March 05, 2022
Tags
Market News
Pharma/Biotech
From
TalkMarkets
DarioHealth Enters Into Strategic Agreement With Sanofi U.S.
March 01, 2022
Tickers
BNTX
DRIO
JNJ
PFE
Tags
Market News
Pharma/Biotech
From
TalkMarkets
How Do You ‘Price’ Innovation?
February 28, 2022
Tags
Pharma/Biotech
ETFs
Market News
From
TalkMarkets
The Canadian Cannabis Report - Monday, Feb. 28
February 28, 2022
Tickers
CNBS
MJ
NEPT
THCX
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers
AMYT
CTIC
GILD
JNJ
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Psychedelic & Marijuana Drug Stocks Continue To Decline
February 27, 2022
Tickers
ATAI
CMPS
CRBP
FTRP
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: Huadong Pharma Enters $662 Million Deal For Two Kiniksa Anti-Inflammatory Drugs
February 26, 2022
Tickers
KNSA
MIRM
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Moderna: An Expected Move Towards The $165 Resistance Level
February 25, 2022
Tickers
MRNA
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Blue Water Vaccines Announces Closing of Initial Public Offering
February 24, 2022
Tickers
BWV
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Insider Buying Detected – Buy This Biotech Now
February 23, 2022
Tickers
ALPN
HZNP
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week
February 21, 2022
Tickers
ALID
ATAI
CMPS
CYBN
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
"Seed-To-Sale" Pot Stocks Index Faltered This Past Week After Two-Week Resurgence
February 21, 2022
Tickers
ACB
CCHWF
CGC
CRLBF
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
MRNA: Moderna Provides an Opportunity for Next Rally
February 21, 2022
Tickers
MRNA
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The Canadian Cannabis Report- Monday, Feb. 21
February 21, 2022
Tickers
ALEAF
CBWTF
CGC
CNBS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
"Prudent" Biotech Bets
February 20, 2022
Tickers
AMGN
GILD
GSK
RCUS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Week In Review: AffaMed Announced US Approval To Start Clinical Trials
February 19, 2022
Tickers
GRCL
LEGN
MRNA
PFE
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Madrigal Pharmaceuticals: A "Best in Class" Biotech Buy
February 17, 2022
Tickers
MDGL
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Tuesday Talk: In The Waiting Place
February 15, 2022
Tickers
CPER
EXPE
MRNA
NOBL
Tags
Commodities
Services
ETFs
From
TalkMarkets
Market Briefing For Tuesday, Feb. 15
February 15, 2022
Tickers
F
GM
LLY
PFE
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Canadian Cannabis Report- Monday, Feb. 14
February 14, 2022
Tickers
ALEAF
CGC
CNBS
HEXO
Tags
Stocks / Equities
Pharma/Biotech
Consumer Goods
From
TalkMarkets
Large Cap Biopharma - Well Positioned For Choppy Markets
February 14, 2022
Tickers
ABBV
AMGN
AZN
BIIB
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Tickers
AEMD
AGIO
ATXI
AZN
Tags
Market News
Healthcare
Stocks / Equities
From
TalkMarkets
Psychedelic And Cannabis Drug Stocks Continue Advance
February 13, 2022
Tickers
ALID
ATAI
AWKNF
CMPS
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: US FDA Rejects Innovent/Lilly PD-1 NDA Based On China-Only Trial Subjects
February 12, 2022
Tickers
LLY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Can Recent Catalysts Breakout BioCryst To New Highs?
February 09, 2022
Tickers
BCRX
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Daily Report: Pfizer (PFE)
February 08, 2022
Tickers
PFE
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.